These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7143594)

  • 1. A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness.
    Diamond DA; Berry SJ; Jewett HJ; Eggleston JC; Coffey DS
    J Urol; 1982 Oct; 128(4):729-34. PubMed ID: 7143594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear shape analysis for the assessment of local invasion and metastases in clinically localized prostate carcinoma.
    Mohler JL; Figlesthaler WM; Zhang XZ; Partin AW; Maygarden SJ
    Cancer; 1994 Dec; 74(11):2996-3001. PubMed ID: 7954263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear roundness factor. A predictor of progression in untreated Stage A2 prostate cancer.
    Epstein JI; Berry SJ; Eggleston JC
    Cancer; 1984 Oct; 54(8):1666-71. PubMed ID: 6478405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear morphometry in automatic biopsy and radical prostatectomy specimens of prostatic carcinoma. A comparison.
    Mohler JL; Metts JC; Zhang XZ; Maygarden SJ
    Anal Quant Cytol Histol; 1994 Dec; 16(6):415-20. PubMed ID: 7710616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin changes predict recurrence after radical prostatectomy.
    Hveem TS; Kleppe A; Vlatkovic L; Ersvær E; Wæhre H; Nielsen B; Kjær MA; Pradhan M; Syvertsen RA; Nesheim JA; Liestøl K; Albregtsen F; Danielsen HE
    Br J Cancer; 2016 May; 114(11):1243-50. PubMed ID: 27124335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer.
    Diamond DA; Berry SJ; Umbricht C; Jewett HJ; Coffey DS
    Prostate; 1982; 3(4):321-32. PubMed ID: 7122329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy.
    Khan MA; Walsh PC; Miller MC; Bales WD; Epstein JI; Mangold LA; Partin AW; Veltri RW
    Cancer; 2003 Dec; 98(12):2583-91. PubMed ID: 14669277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections.
    Mohler JL; Partin AW; Epstein JI; Lohr WD; Coffey DS
    J Urol; 1988 May; 139(5):1085-90. PubMed ID: 3283380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma.
    Nativ O; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
    J Urol; 1990 Aug; 144(2 Pt 1):303-6. PubMed ID: 1695690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of prostate cancer in Senegal: what is being done?].
    Niang L; Ndoye M; Ouattara A; Jalloh M; Labou M; Thiam I; Kouka SC; Diaw JJ; Gueye SM
    Prog Urol; 2013 Jan; 23(1):36-41. PubMed ID: 23287482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum levels of early prostate cancer antigen (EPCA) predict prostate cancer progression in patients undergoing radical prostatectomy.
    Zhao Z; Ma W; Zeng G; Qi D; Ou L; Liang Y
    Prostate; 2012 Feb; 72(3):270-9. PubMed ID: 21630293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer.
    Partin AW; Steinberg GD; Pitcock RV; Wu L; Piantadosi S; Coffey DS; Epstein JI
    Cancer; 1992 Jul; 70(1):161-8. PubMed ID: 1606538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.
    Epstein JI
    J Urol; 2011 Sep; 186(3):790-7. PubMed ID: 21788055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The morbidity of radical prostatectomy for multifocal stage I prostatic adenocarcinoma.
    Nichols RT; Barry JM; Hodges CV
    J Urol; 1977 Jan; 117(1):83-4. PubMed ID: 830976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of prostatic cancer.
    Arvola I; Lilius HG; Uusi-Penttilä S
    Ann Chir Gynaecol Fenn; 1972; 61(1):25-9. PubMed ID: 5021539
    [No Abstract]   [Full Text] [Related]  

  • 17. Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases.
    Perry-Keene J; Ferguson P; Samaratunga H; Nacey JN; Delahunt B
    Histopathology; 2014 Feb; 64(3):399-404. PubMed ID: 24118022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density.
    Allan RW; Sanderson H; Epstein JI
    J Urol; 2003 Aug; 170(2 Pt 1):370-2. PubMed ID: 12853777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis.
    Partin AW; Walsh AC; Pitcock RV; Mohler JL; Epstein JI; Coffey DS
    J Urol; 1989 Nov; 142(5):1254-8. PubMed ID: 2810502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of radical prostatectomy in the management of prostatic cancer.
    Walsh PC; Lepor H
    Cancer; 1987 Aug; 60(3 Suppl):526-37. PubMed ID: 3594391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.